Improving Pharmaceutical

Integration and Patient Adherence

When Patients Cannot Feel Effects of Medication

A solution for patient acquisition, adherence and integration into population management systems through the integration of novel

diagnostics

Interrelated Risks and Opportunities

Pharmaceutical Companies

Patients

Health Care Providers

ACOs Population & Quality

Mgmt.

• Identifying new patients• Cost of patient acquisition• Patient adherence

• 20% of Patients difficult to treat• 20% of Patients seen too often• Patient outcomes/adherence

• Population management• Shared risk• Patient outcomes/adherence

• Reaching difficult patients• Preferred formulary status• Patient outcomes/adherence

Pharmaceutical Companies = “Silver Lining”

Pharmaceutical Companies

Patients

Health Care Providers

ACOs Population & Quality

Mgmt.

• Identifying new patients• 20% not being reached

• Reduce cycle time and cost of patient acquisition• Waiting for HCP to identify

• Patient outcomes/adherence• Demonstrate effectiveness via adoption and

adherence• Support ACO and HCP population management

Revolutionary Collection Media

The AdvanceDx100 Serum Separator Collection Card is a revolutionary new way to collect, store, and transport micro-sample blood specimens for laboratory analysis. It supersedes all previous collection methods in its ease of use and accuracy. The secret to this patented device lies in its special blood transport method that actually separates the blood serum from the red blood cells right on the card. This is the same process that occurs when a tube of blood is "spun down" in a centrifuge before processing. The card is then dried and is ready to send to the laboratory for analysis without any further special handling.

No medical training is needed to complete the collection process.

Anyone can collect a valid specimen.

Simple Collection, Transport, Accurate Testing and Reporting

The yield of a Bayshore Labs collaboration

PatientAdherence

&Management

Support

Leveraged Patient Screening Partner• An adjunct to discovering appropriate

patients for therapies• 3 million screened patients over age 40

annually• 53% Female, 47% Male• Can provide DTC data or blinded• Distribute Rx vouchers & lab results

Diagnostic Testing, Logistics & Reporting• Rx supported, regular interval testing

provides patient with validation of Rx intervention

• Eliminate inconvenience to patient and physician with ADx100 card

• Improve patient satisfaction and outcomes• Support population management

Identifying and acquiring new

patients

Simple, seven step process to improving patient adherence

Brand Manager measures improved

acquisition and adherence

Patient or BCL can report test

results

Reward fulfillment

DTC, Screening partner or native

sales force

Reward mechanism

Complementary testing and/or

voucher

Deploy via patient screening partner or native

sales force

Determine tests for acquisition vs. adherence

Brand Manager allocates funding